17 /100
LOW RISK
Score updated Jul 14, 2026

HIMS — Hims & Hers Health, Inc. Dilution Risk Tracker

Track HIMS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HIMS — Get alerts when the score changes →

As of July 14, 2026, Hims & Hers Health, Inc. (HIMS) has a DilutionWatch DilutionScore of 17/100, rated LOW dilution risk. Hims & Hers Health, Inc. has a market capitalization of $6.05B, 223.08M shares outstanding, 445 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HIMS.
🔔 Track HIMS — Get forecast alerts →

💹 Market Data

Market Cap$6.05B
Shares Outstanding223.08M
Float210.89M
Cash$222.27M
Debt$1.13B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.4% shares (2026Q1 vs prior)
445 institutional holders · 256.17M shares
#1 BlackRock, Inc. 26.34M shares
#2 SUSQUEHANNA INTERNATIONAL GROUP, LLP 25.05M shares
#3 MORGAN STANLEY 20.09M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest61.17M
Days to Cover3.2
% of Float29.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Jun 23, 2026
4 INSIDER TRANSACTION Jun 23, 2026
4 INSIDER TRANSACTION Jun 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for HIMS Shareholders

Hims & Hers Health, Inc. (HIMS) has a DilutionScore of 17/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for HIMS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HIMS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HIMS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HIMS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HIMS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HIMS
📊 HIMS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HIMS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.